Clinical Scorecard: Development of Nomograms for Assessing Severe Pulmonary Hypertension and Prognosis in Patients with Chronic Obstructive Pulmonary Disease Using Non-Invasive Metrics
At a Glance
Category
Detail
Condition
Severe Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease
Key Mechanisms
Non-invasive clinical parameters predicting severe PH and mortality risk
Target Population
Patients with Chronic Obstructive Pulmonary Disease (COPD)
Care Setting
Pulmonary hospital
Key Highlights
Nomograms developed for predicting severe PH and survival in COPD-PH patients
Key predictors for severe PH include peak SpO2, peak VO2/kg, peak HR, and PASP
Survival predictors include age, DLCO% predicted, and VE/VCO2 slope
C-index for severe PH prediction models was 0.906 and 0.93 for training and validation cohorts
C-index for survival prediction models was 0.80 and 0.69 for training and validation cohorts
Guideline-Based Recommendations
Diagnosis
Diagnosis of COPD based on GOLD criteria with FEV1/FVC < 0.70
Diagnosis of COPD-PH with mPAP >20 mmHg and no alternative causes
Management
Use of nomograms for risk stratification and decision-making in COPD-PH patients
Monitoring & Follow-up
Regular assessment of non-invasive metrics to predict PH severity and survival
Risks
Severe PH is an independent risk factor for adverse outcomes and mortality in COPD
Patient & Prescribing Data
179 COPD patients, including those with severe PH
Nomograms may facilitate timely initiation of targeted therapeutic interventions
Clinical Best Practices
Incorporate non-invasive metrics in routine assessments for COPD patients
Utilize nomograms for individualized patient risk assessment
